Development and Implementation of Mobile Antibiograms to Optimize Empirical Antibiotic Prescriptions Among Prescribers in Tertiary Hospitals in Tanzania

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMuhimbili University of Health and Allied Sciences

About this trial

Antimicrobial resistance (AMR) is a critical issue, especially in Africa, with resistance to common antibiotics reaching 100% in some areas. In Tanzania, limited access to culture tests and antibiograms forces healthcare providers to rely on experience for prescribing, heightening AMR risks. This study aims to determine the effectiveness of mobile antibiograms in optimizing empirical antibiotic therapy in tertiary hospitals in Tanzania.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

All prescribers working in the selected tertiary referral hospitals

All prescribers owning smartphones

Prescribers who consent to take part in the study

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Mobile antibiogram application

    Other intervention

    A mobile antibiogram application software containing antibiotic sensitivity test results specific to the health facility. This mobile antibiogram application will guide decision support for empirical prescription.

  • standard of care

    Other intervention

    Participants will be assigned to manual antibiogram only.

Treatment groups

300 Participants
are divided into 2 treatment groups
Group A: standard of careActive comparator 1 intervention
Group B: Mobile antibiogramExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Pattern of antibiotic use

Proportional change in antibiotic use among admitted patients

Time frame
12 months

Secondary outcomes

1

Pattern of antibiotic resistance

Number of resistances to antibiotics among admitted patients

Time frame
12 months
2

Acceptability of mobile antibiograms

% of acceptability of mobile antibiograms among prescribers

Time frame
12 months
3

Feasibility of mobile antibiograms

% of feasibility mobile antibiogram among prescribers in tertiary referral hospitals in Tanzania

Time frame
12 months
4

Adoption of mobile antibiogram

% of adoption of mobile antibiogram among prescribers in tertiary referral hospitals in Tanzania

Time frame
12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: